BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27690083)

  • 1. The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.
    Leisi R; Von Nordheim M; Ros C; Kempf C
    Viruses; 2016 Sep; 8(10):. PubMed ID: 27690083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.
    Leisi R; Di Tommaso C; Kempf C; Ros C
    Viruses; 2016 Feb; 8(3):61. PubMed ID: 26927158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal 5-68 amino acids domain of the minor capsid protein VP1 of human parvovirus B19 enters human erythroid progenitors and inhibits B19 infection.
    Zou W; Ning K; Xu P; Deng X; Cheng F; Kleiboeker S; Qiu J
    J Virol; 2021 Jun; 95(14):. PubMed ID: 33952637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells.
    Bircher C; Bieri J; Assaraf R; Leisi R; Ros C
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VP1u of Human Parvovirus B19: A Multifunctional Capsid Protein with Biotechnological Applications.
    Ros C; Bieri J; Leisi R
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33352888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
    Bieri J; Ros C
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.
    Leisi R; Ruprecht N; Kempf C; Ros C
    J Virol; 2013 Dec; 87(24):13161-7. PubMed ID: 24067971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19.
    Nogueira MLC; Lakshmanan R; Rivière G; Mietzsch M; Bennett A; McKenna R; Long JR
    Biomol NMR Assign; 2024 Jun; ():. PubMed ID: 38904726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19.
    Caldas Nogueira ML; Lakshmanan R; Rivière G; Mietzsch M; Bennett A; McKenna R; Long JR
    Res Sq; 2024 Jun; ():. PubMed ID: 38883784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.
    Hsu TC; Chiu CC; Chang SC; Chan HC; Shi YF; Chen TY; Tzang BS
    Virulence; 2016; 7(2):110-8. PubMed ID: 26632342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Targeting of Proerythroblasts and Erythroleukemic Cells by the VP1u Region of Parvovirus B19.
    Leisi R; von Nordheim M; Kempf C; Ros C
    Bioconjug Chem; 2015 Sep; 26(9):1923-30. PubMed ID: 26240997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
    Wolfisberg R; Ruprecht N; Kempf C; Ros C
    J Virol Methods; 2013 Oct; 193(1):215-25. PubMed ID: 23764418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Dynamics and Activity of B19V VP1u during the pHs of Cell Entry and Endosomal Trafficking.
    Lakshmanan RV; Hull JA; Berry L; Burg M; Bothner B; McKenna R; Agbandje-McKenna M
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.
    Adamson-Small LA; Ignatovich IV; Laemmerhirt MG; Hobbs JA
    Virus Res; 2014 Sep; 190():8-16. PubMed ID: 24998884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis.
    Chen DY; Tzang CC; Liu CM; Chiu TM; Lin JW; Chuang PH; Kuo CW; Tzang BS; Hsu TC
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of AXL as a co-receptor for human parvovirus B19 infection of human erythroid progenitors.
    Ning K; Zou W; Xu P; Cheng F; Zhang EY; Zhang-Chen A; Kleiboeker S; Qiu J
    Sci Adv; 2023 Jan; 9(2):eade0869. PubMed ID: 36630517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
    Bönsch C; Kempf C; Ros C
    J Virol; 2008 Dec; 82(23):11784-91. PubMed ID: 18815302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The VP1 unique region of human parvovirus B19 and human bocavirus induce lung injury in naïve Balb/c mice.
    Lin CY; Chung YH; Shi YF; Tzang BS; Hsu TC
    PLoS One; 2018; 13(8):e0202667. PubMed ID: 30114253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of a Unique Region of Parvovirus B19 Capsid Protein VP1 on Endothelial Cells.
    Rinkūnaitė I; Šimoliūnas E; Bironaitė D; Rutkienė R; Bukelskienė V; Meškys R; Bogomolovas J
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking.
    Bieri J; Leisi R; Bircher C; Ros C
    PLoS Pathog; 2021 Apr; 17(4):e1009434. PubMed ID: 33878123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.